“Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma”. Journal of Carcinogenesis, vol. 24, no. 8s, Oct. 2025, pp. 553-62, https://doi.org/10.64149/J.Carcinog.24.8s.553-562.